Report copyright - CYSTIC FIBROSIS FOUNDATION GEORGIA …...cystic fibrosis in approximately eight percent of the CF population. Orkambi, approved in July 2015, could eventually benefit nearly 50 percent
Please pass captcha verification before submit form